ECMO Devices Market Size, Share, Growth, and Industry Analysis, By Type (VA (Veno-Arterial) ECMO,VV (Veno-Venous) ECMO), By Application (Adult,Neonatal,Pediatric), Regional Insights and Forecast to 2035

ECMO Devices Market Overview

Global ECMO Devices market size, valued at USD 258.4 million in 2026, is expected to climb to USD 362.2 million by 2035 at a CAGR of 3.8%.

The ECMO Devices Market is expanding due to the rising prevalence of severe respiratory and cardiac conditions, with over 20 million global cases of acute respiratory distress syndrome (ARDS) reported annually. ECMO utilization increased by 35% between 2020 and 2023 due to pandemic-driven demand. Approximately 60% of ECMO procedures are performed in tertiary care hospitals, while 25% are conducted in specialized cardiac centers. Portable ECMO devices account for nearly 18% of installations globally. Oxygenators represent 40% of total device components used. Adult patients contribute to 70% of ECMO usage, while neonatal cases account for 20% and pediatric cases for 10%.

The USA ECMO Devices Market accounts for nearly 45% of global procedures, with over 10,000 ECMO runs annually across 300+ certified centers. Approximately 65% of ECMO usage in the USA is for respiratory support, while 35% is for cardiac indications. Adult ECMO usage exceeds 75%, reflecting high prevalence of cardiovascular diseases affecting over 18 million individuals. Neonatal ECMO procedures represent 15%, supported by over 1,200 NICUs nationwide. Portable ECMO adoption increased by 28% between 2021 and 2024. More than 80% of ECMO systems in the USA use advanced centrifugal pumps, improving survival rates by approximately 12%.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Approximately 65% demand increase driven by rising incidence of respiratory disorders, 40% growth in cardiac failure cases, 55% adoption in critical care units, and 30% increase in ICU admissions requiring life-support technologies.
• Major Market Restraint: Nearly 50% cost burden in hospitals, 35% shortage of skilled professionals, 25% device-related complications, and 20% limited accessibility in developing regions restrict widespread ECMO device adoption.
• Emerging Trends: Around 45% shift toward portable ECMO systems, 38% integration of AI monitoring, 28% increase in home-based ECMO trials, and 32% adoption of minimally invasive cannulation techniques.
• Regional Leadership: North America holds approximately 45% share, Europe contributes 30%, Asia-Pacific accounts for 20%, and Middle East & Africa represent nearly 5% of ECMO Devices Market share.
• Competitive Landscape: Top 2 players hold nearly 55% combined share, while top 5 companies control around 80%, with 35% market dominated by advanced oxygenator technologies and 25% by pump innovations.
• Market Segmentation: VV ECMO accounts for nearly 60% share, VA ECMO contributes 40%, adult applications dominate with 70%, neonatal 20%, and pediatric applications represent 10% of total usage.
• Recent Development: Approximately 40% of manufacturers launched upgraded systems, 30% increase in R&D spending, 25% rise in FDA approvals, and 20% expansion in portable ECMO product lines.

ECMO Devices Market Latest Trends

The ECMO Devices Market Trends indicate strong technological advancement with over 50% of new systems incorporating digital monitoring capabilities. Portable ECMO systems have seen a 35% increase in adoption due to their mobility and emergency usability. Approximately 42% of hospitals are transitioning toward compact ECMO machines to reduce ICU space requirements by nearly 20%. Artificial intelligence integration has improved patient monitoring accuracy by 30%, while automated flow control systems have enhanced efficiency by 25%.

Hybrid ECMO systems combining cardiac and respiratory support functionalities now account for 18% of installations globally. Single-use oxygenators have gained traction, representing 45% of consumable demand due to infection control benefits. Around 60% of ECMO centers are investing in training programs to address a 35% shortage of skilled operators. The ECMO Devices Market Growth is further supported by increasing adoption in non-traditional settings, including transport ECMO, which has expanded by 28% globally.

ECMO Devices Market Dynamics

ECMO Devices Market dynamics refer to the set of measurable factors and statistical forces that influence the behavior, structure, and performance of the ECMO Devices Market over time. These dynamics include drivers, restraints, opportunities, and challenges, each contributing to changes in ECMO Devices Market Size, ECMO Devices Market Share, and ECMO Devices Market Growth patterns. For instance, more than 65% of demand fluctuations in the ECMO Devices Market are influenced by rising ICU admissions, while nearly 40% of variation is linked to technological advancements such as portable ECMO systems. Market dynamics also quantify how external and internal variables impact adoption rates, with approximately 70% of ECMO utilization driven by adult patient demand, and 30% influenced by pediatric and neonatal applications. Around 50% of market expansion factors are tied to increasing respiratory disease cases, while 35% are associated with cardiovascular conditions. Additionally, nearly 25% of market limitations arise from cost constraints, and 20% are due to skilled workforce shortages.

DRIVER

" Rising demand for critical care support systems"

The ECMO Devices Market is significantly driven by the increasing incidence of severe respiratory and cardiac diseases, affecting over 25 million individuals globally. Approximately 65% of ICU patients with ARDS require advanced life support, boosting ECMO adoption. Cardiovascular diseases contribute to 32% of global deaths, increasing the need for VA ECMO systems. The demand for ECMO surged by 40% during pandemic periods, highlighting its importance. Hospitals with ECMO capabilities have shown a 20% improvement in survival rates, further driving adoption across developed healthcare systems.

RESTRAINT

" High operational and equipment costs"

ECMO devices require substantial investment, with approximately 50% of hospitals reporting cost-related challenges. Maintenance costs contribute to nearly 25% of total operational expenses. Training skilled personnel requires 12–18 months, creating a 35% workforce gap globally. Additionally, complications such as bleeding and thrombosis occur in nearly 20% of cases, limiting usage. Around 30% of smaller healthcare facilities lack infrastructure to support ECMO systems, restricting ECMO Devices Market Size expansion.

OPPORTUNITY

" Expansion in emerging healthcare markets"

Emerging economies contribute to nearly 40% untapped potential in the ECMO Devices Market Opportunities landscape. Asia-Pacific has seen a 25% increase in ECMO installations due to rising healthcare investments. Government initiatives in developing regions have improved ICU capacity by 30%. Portable ECMO devices are expected to address accessibility gaps, with adoption increasing by 28% in rural healthcare settings. Training programs have expanded by 35% globally, enhancing workforce readiness and supporting market penetration.

CHALLENGE

" Limited skilled workforce and clinical risks"

Approximately 35% shortage of trained ECMO specialists remains a critical challenge. Complication rates such as infection (15%) and mechanical failures (10%) impact clinical outcomes. Nearly 20% of ECMO procedures require emergency interventions due to device-related issues. Regulatory approvals take 12–24 months, delaying product launches by 18%. Around 25% of hospitals face challenges in maintaining consistent ECMO operation standards, impacting overall ECMO Devices Market Outlook.

ECMO Devices Market Segmentation

The ECMO Devices Market Segmentation is categorized by type and application, with VV ECMO dominating at 60% share due to its effectiveness in respiratory failure cases. VA ECMO holds 40% share, primarily used in cardiac conditions. Adult applications dominate with 70%, while neonatal accounts for 20% and pediatric represents 10%. Increasing ICU admissions and critical care demand continue to influence segmentation dynamics, with portable ECMO systems contributing to 18% of installations.

Download Free Sample to learn more about this report.

By Type

VA (Veno-Arterial) ECMO: VA ECMO accounts for approximately 40% of the ECMO Devices Market Share, primarily used in cardiac support cases. Around 60% of patients with cardiogenic shock require VA ECMO intervention, with cardiovascular diseases affecting over 18 million individuals annually. VA ECMO supports both heart and lung function, making it critical in cases of cardiac arrest, which impacts nearly 356,000 out-of-hospital incidents annually in developed regions. Approximately 35% of ECMO centers prioritize VA ECMO systems due to increasing cardiac complications. Survival rates improve by nearly 25% with VA ECMO support, particularly in acute heart failure cases. However, complication rates such as bleeding occur in about 20% of VA ECMO procedures, which slightly limits adoption. Despite this, technological advancements have improved pump efficiency by 30%, making VA ECMO a vital segment in the ECMO Devices Market Growth.

VV (Veno-Venous) ECMO: VV ECMO dominates the ECMO Devices Market with nearly 60% market share, driven by its extensive use in respiratory failure cases. Around 70% of ARDS patients require VV ECMO support, with ARDS affecting over 10 million individuals globally each year. VV ECMO is primarily used for lung support and is preferred due to its lower complication rates compared to VA ECMO. Approximately 65% of hospitals prefer VV ECMO systems because they reduce mortality rates by nearly 20% in severe respiratory cases. During pandemic periods, VV ECMO usage increased by 40%, highlighting its importance in managing respiratory crises. Portable VV ECMO systems have seen a 30% rise in adoption, enabling usage in emergency and transport settings. Additionally, advancements in oxygenator technology have improved gas exchange efficiency by 25%, strengthening VV ECMO’s dominance in the ECMO Devices Market Trends.

By Application

Adult: The adult segment dominates the ECMO Devices Market Size with approximately 70% share, driven by the high prevalence of respiratory and cardiovascular diseases. Over 75% of ECMO procedures are performed on adults, with cardiovascular diseases contributing to 32% of global deaths. ICU admissions among adults have increased by 25%, directly influencing ECMO demand. Adult ECMO usage has shown a 30% improvement in survival rates for severe respiratory and cardiac conditions. Approximately 65% of adult ECMO cases are respiratory-related, while 35% are cardiac-related. The adoption of portable ECMO devices in adult care has increased by 28%, enabling rapid deployment in emergency situations. Additionally, advanced monitoring systems have improved treatment efficiency by 20%, further boosting the ECMO Devices Market Outlook in this segment.

Neonatal: Neonatal ECMO represents around 20% of the ECMO Devices Market Share, primarily used for infants with severe respiratory or cardiac conditions. Approximately 1 in 500 newborns requires critical respiratory support, with neonatal ECMO offering survival rates exceeding 80%. Over 1,200 neonatal intensive care units (NICUs) globally are equipped with ECMO systems. Around 35% of neonatal respiratory failure cases require ECMO intervention, particularly in conditions like meconium aspiration syndrome. Technological advancements have reduced complication rates by 15%, improving outcomes. Additionally, oxygenator efficiency improvements of 25% have enhanced neonatal care performance. The neonatal segment continues to grow due to a 20% increase in preterm births requiring intensive care support.

Pediatric: The pediatric segment accounts for approximately 10% of the ECMO Devices Market, supporting children with congenital and acquired cardiac or respiratory conditions. Around 5% of pediatric cardiac patients require ECMO support, particularly in congenital heart defects affecting nearly 1 in 100 births. Pediatric ECMO improves survival rates by nearly 25%, especially in post-surgical cardiac cases. Approximately 20% of pediatric ECMO procedures are associated with congenital heart disease, while 30% are related to severe respiratory infections. Adoption of advanced ECMO systems in pediatric care has increased by 22%, supported by improved ICU infrastructure. Additionally, training programs for pediatric ECMO specialists have expanded by 30%, addressing workforce shortages and enhancing treatment outcomes within the ECMO Devices Market Growth trajectory.

Regional Outlook for  ECMO Devices Market

Regional outlook in the ECMO Devices Market refers to the quantitative and comparative evaluation of market performance across different geographic regions, based on measurable indicators such as procedure volume, device adoption rates, healthcare infrastructure, and patient demographics. It identifies how regions like North America with approximately 45% market share, Europe with 30%, Asia-Pacific with 20%, and Middle East & Africa with 5% contribute to the overall ECMO Devices Market Size and ECMO Devices Market Share. This analysis considers factors such as the number of ECMO procedures, where North America performs over 12,000 procedures annually, while Europe accounts for nearly 8,000 procedures and Asia-Pacific exceeds 5,000 procedures per year. It also evaluates infrastructure metrics, including ICU capacity growth of 30% in Asia-Pacific and 25% in Europe, along with technological adoption rates such as 30% portable ECMO usage in developed regions.

Download Free Sample to learn more about this report.

North America

The ECMO Devices Market in North America dominates globally with approximately 49% market share, driven by advanced healthcare infrastructure and a high number of ECMO centers . The United States alone contributes nearly 82% of regional demand, supported by over 780 ECMO reporting centers globally, many of which are concentrated in North America . In the ECMO Devices Market Analysis, adult patient usage accounts for approximately 59% of ECMO procedures, reflecting the high prevalence of cardiovascular and respiratory diseases . Cardiac applications dominate with nearly 49% share, while respiratory indications account for around 35%, highlighting the growing need for advanced life-support systems . The ECMO Devices Market Insights show that approximately 61% of hospitals in North America have adopted advanced ECMO monitoring systems, improving patient survival outcomes to around 71% in recent studies . Additionally, ECMO utilization has increased significantly, with adult ECMO runs per center rising from 4 to 15 annually between 2009 and 2022, indicating a strong expansion in clinical adoption . This positions North America as the leading region in the ECMO Devices Market Report and ECMO Devices Industry Analysis.

Europe

The ECMO Devices Market in Europe holds approximately 22%–26% share, driven by strong healthcare systems and widespread adoption of advanced critical care technologies. Countries such as Germany, France, and the United Kingdom contribute nearly 65% of regional demand, with high adoption rates in tertiary care hospitals. In the ECMO Devices Market Research Report, around 57% of ECMO usage in Europe is associated with respiratory failure conditions such as Acute Respiratory Distress Syndrome (ARDS), which is a leading indication for VV ECMO . Cardiac applications contribute approximately 41% of usage, reflecting the increasing incidence of heart-related emergencies. The ECMO Devices Market Trends highlight that approximately 49% of healthcare facilities in Europe have implemented advanced ECMO systems with integrated monitoring technologies, improving clinical efficiency by nearly 24%. Additionally, research institutions account for approximately 21% of ECMO installations, supporting innovation and clinical trials. The region also demonstrates strong survival outcomes, with ECMO-supported patient survival rates averaging around 70%, reinforcing Europe’s role in the ECMO Devices Market Outlook.

Asia-Pacific

The ECMO Devices Market in Asia-Pacific accounts for approximately 20%–24% share, driven by rapid healthcare infrastructure development and increasing awareness of advanced life-support technologies. China, Japan, and India collectively contribute nearly 68% of regional demand, with China alone accounting for approximately 38%. In the ECMO Devices Market Analysis, approximately 61% of ECMO applications in Asia-Pacific are concentrated in intensive care units, while emergency medicine accounts for around 23% and cardiology for 16% . The rising incidence of cardiac arrest, estimated at 30 to 97 cases per 100,000 population, is a key driver for ECMO adoption . The ECMO Devices Market Insights indicate that approximately 43% of hospitals in Asia-Pacific are investing in ECMO technology upgrades, improving treatment efficiency by nearly 25%. Additionally, around 37% of new ECMO installations are in emerging economies, supported by government initiatives and increasing healthcare expenditure. The number of ECMO centers is steadily increasing, contributing to approximately 36% growth in adoption rates, strengthening the region’s position in the ECMO Devices Market Growth.

Middle East & Africa

The ECMO Devices Market in the Middle East & Africa represents approximately 5%–7% of global share, with adoption primarily driven by increasing investments in healthcare infrastructure and critical care facilities. Countries such as Saudi Arabia, UAE, and South Africa contribute nearly 55% of regional demand. In the ECMO Devices Market Research Report, approximately 42% of ECMO usage in this region is linked to cardiac applications, while respiratory applications account for around 33%. The adoption of ECMO technology has increased by nearly 29%, supported by government initiatives and the expansion of tertiary care hospitals. The ECMO Devices Market Trends show that approximately 34% of healthcare providers in the region are investing in advanced ECMO systems, improving patient outcomes by nearly 23%. Additionally, around 28% of installations are equipped with high-performance systems capable of handling complex cases. Despite challenges such as limited skilled professionals, approximately 31% of institutions are focusing on training programs and partnerships to enhance ECMO adoption, contributing to the gradual expansion of the ECMO Devices Market Outlook in the region.

List of Top ECMO Devices Companies

• Medtronic
• Getinge (Maquet)
• LivaNova (Sorin)
• Terumo
• Fresenius Medical Care
• Chinabridge(Shenzhen) Medical

Medtronic – holds approximately 30% market share with over 5,000 ECMO system installations globally

Getinge (Maquet) – accounts for nearly 25% market share with presence in over 50 countries

Investment Analysis and Opportunities

The ECMO Devices Market Opportunities are expanding with global healthcare investments increasing by 35% in critical care infrastructure. Approximately 40% of hospitals are allocating budgets for ECMO system upgrades. Venture capital investments in ECMO technologies increased by 28% between 2022 and 2024. Emerging markets contribute nearly 45% of new investment opportunities due to rising ICU demand. Portable ECMO systems attract 30% of total investments, driven by mobility needs. Training programs receive 20% of funding to address workforce shortages. Government initiatives in developing regions increased healthcare spending by 25%, boosting ECMO adoption.

Private equity and institutional funding in medical device innovation have grown by 28% between 2022 and 2025, with nearly 32% of investments focused on portable ECMO technologies. Around 25% of global investments are allocated to training programs and simulation labs to address a 35% shortage of skilled ECMO professionals. Government-backed healthcare programs have increased funding by 20%, particularly in Asia-Pacific and Middle East regions. Additionally, approximately 38% of manufacturers are investing in R&D facilities, while 30% are focusing on automation and AI integration. These investment trends are aligned with ECMO Devices Market Growth strategies, where nearly 50% of hospitals plan to upgrade ECMO systems within 3 years, reinforcing long-term ECMO Devices Market Opportunities.

New Product Development

New product development in the ECMO Devices Market Trends focuses on portability, automation, and efficiency. Approximately 50% of new ECMO systems launched between 2023 and 2025 feature compact designs. AI-based monitoring systems improve patient outcomes by 30%. Single-use oxygenators account for 45% of new product launches. Battery-operated portable ECMO devices have increased by 35%, enabling transport applications. Hybrid ECMO systems combining respiratory and cardiac support represent 20% of innovations. Advanced centrifugal pumps improve efficiency by 25%. Nearly 40% of manufacturers are focusing on reducing device size by 30% while maintaining performance standards.

Artificial intelligence integration is present in around 40% of